Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 300-212-6 | CAS number: 93924-19-7 Hollow ceramic spheres formed as a part of the ash in power stations burning pulverized coal. Composed primarily of the oxides of aluminium, iron and silicon and contain carbon dioxide and nitrogen within the sphere.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 27 Nov 2007 - 30 Jan 2008
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP - Guideline study. In accordance to the ECHA guidance document “Practical guide 6: How to report read-across and categories (March 2010)”, the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on a read-across substance.”
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 2016
- Deviations:
- yes
- Remarks:
- 200 instead of 500 erythrocytes for bone marrow, 2000 instead of 4000 immature erythrocytes per animal scored
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- Ashes (residues), coal
- EC Number:
- 931-322-8
- Molecular formula:
- Not applicable (UVCB substance)
- IUPAC Name:
- Ashes (residues), coal
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Breeding farm BioTest s.r.o., Konárovice, 28125, Czech Republic, RČH CZ 21760152
- Age at study initiation: 6-7 weeks
- Weight at study initiation: females 169.60 - 177.62 g, males 200.81 - 212.09 g
- Assigned to test groups randomly: yes
- Diet (e.g. ad libitum): Complete pelleted diet for rats ad libitum (ST 1 Bergman, Mill Kocanda, Jesenice by Prague)
- Water (e.g. ad libitum): Drinking water ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%):30-70
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 27 Nov 2007 To: 07 Dec 2007
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: 0.5% methylcelulose in water
- Concentration of test material in vehicle: adjusted to body weight
- Amount of vehicle (if gavage or dermal): 1 mL/100 g bw - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The test substance was suspended in 0.5% methylcelulose in water prior to administration via oral gavage, the concentration in vehicle was adjusted to body weight in order to achieve a constant administration volume of 1 mL/100 g bw.
- Duration of treatment / exposure:
- 24 and 48 h
- Frequency of treatment:
- Single administration
- Post exposure period:
- Not applicable
Doses / concentrations
- Dose / conc.:
- 2 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 30
- Control animals:
- yes, concurrent no treatment
- yes, concurrent vehicle
- Positive control(s):
- - Positive control: Cyclophosphamide monohydrate
- Route of administration: intraperitoneal injection (solution in water)
- Doses / concentrations: 20 mg/kg bw . The dose level of cyclophosphamide was chosen on the basis of literature data.
- Duration of exposure: 24 h
- No. of animals per sex per dose: 5
Examinations
- Tissues and cell types examined:
- Bone marrow cells from the femora
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
The appropriate concentrations of the test item were determined from a pilot experiment.
DETAILS OF SLIDE PREPARATION:
Bone marrow harvest
Bone marrow cells were obtained from the femora immediately after animal sacrifice. After excising and careful cleaning of the bone, both femur ends were clipped off. The bone marrow was gently flushed from the bone with 1 mL of bovine serum into a tube. The acquired bone marrow was suspended and mixed in the bovine serum using a syringe with thin needle.
Preparation of bone marrow smears
After centrifugation (5 min, 1000 rpm), the supernatant was gently removed. One drop of bovine serum was added to the cell sediment which was then resuspended by mixing. One drop of the cell suspension was placed onto a slide and a smear was prepared using a pusher slide. Two bone marrow smears were prepared per animal.
Staining of the bone marrow smears
After drying (20 minutes, 60 °C) the smears were fixed with ethanol for 5 min, rinsed twice with distilled water and stained with 5% Giemsa solution for 15 min.
Examination of the bone marrow smears
Stained smears were examined with a light microscope. 200 erythrocytes were evaluated per animal as to the proportion of immature (polychromatic) and mature (normochromatic) erythrocytes („cytotoxicity index“) in bone marrow. At least 2000 polychromatic erythrocytes per animal were scored for the incidence of micronucleated immature erythrocytes.
Criteria for distinguishing the micronuclei
colour: purple
form: generally round or almond shaped, (occasional lightly stained and ring shaped micronuclei may occur)
borders: sharp
size: 5-20% of polychromatic erythrocyte size
Scoring of micronucleated immature erythrocytes
- number of immature erythrocytes with micronuclei - Evaluation criteria:
- The criteria for determining a positive result are dose-related increase in the number of micronucleated cells or a clear increase in the number of micronucleated cells in a single dose group at a single sampling time.
- Statistics:
- The proportion of immature erythrocytes (cytotoxic index) and the number of micronucleated immature erythrocytes were determiend for each animal. The final count of micronucleated immature erythrocytes was adjusted to counts per 2000 erythrocytes per animal.
Mean values and standard deviations were calculated for each group of animals.
The statistical analysis was performed by the Analysis of Variance (ANOVA) test (software QC.Expert 2.5, Trilobyte, Statistical Software, Czech Rep.). Each of treatment groups was compared to the negative control group.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
Pilot experiment:
The experiment was performed because there were no suitable data, which could be used for the dose selection. The pilot test was performed using the same strain of animals and the same treatment regimen used in the main study.
The test substance was administered by gavage using a stomach tube. Clinical symptoms of toxicity were monitored after application. After euthanasia the indication of cytotoxicity in the bone marrow was evaluated by the ratio of immature erythrocytes to the total number of erythrocytes (“cytotoxicity index”). This ratio was determined from 200 erythrocytes.
Dose levels in pilot experiment and duration of exposition:
In the pilot experiment, 15 females (12 in the treatment groups and 3 animals in the control group) were used.
Negative control and three dose levels of the test substance were tested in the pilot experiment:
1. 2000 mg/kg bw for 24 h (3 animals)
2. 2000 mg/kg bw for 48 h ( 3 animals)
3. 1000 mg/kg of bw for 24 h (3 animals)
4. 500 mg/kg bw for 24 h (3 animals)
5. negative control group: 0.5% methylcelulose in water (3 animals)
Clinical observations:
No symptoms of toxicity were observed at any dose level.
Bone marrow harvest:
For the determination of the “cytotoxicity index”, bone marrow was harvested from all animals at 24 h after application and at the dose level 2000 mg/kg bw also at 48 h after application.
Evaluation of the pilot experiment and selection of doses:
A decrease in the “cytotoxicity index” was not observed at any dose level.
For the main study the dose level 2000 mg/kg bw was chosen (limit test).
RESULTS OF DEFINITIVE STUDY
Clinical observations:
No animal died during the main experiment and no signs of toxicity were observed in any animal in the treatment groups as well as in the negative and positive control groups.
Examination of the bone marrow smears:
The ratio of immature erythrocytes to total erythrocytes is shown in Table 1.
No statistically significant changes in the ratio of immature erythrocytes to the total number of erythrocytes were observed. A statistically significant decrease was seen in the positive control group compared to the negative control.
Count of micronucleated immature erythrocytes:
The mean numbers of micronucleated immature erythrocytes (IME) in males and females are summarised in the tables 2 and 3, respectively.
No statistically significant change in the number of micronucleated immature erythrocytes were observed. A statistically significant increase in the number of micronucleated immature erythrocytes was observed in the positive control group compared to the negative control.
Any other information on results incl. tables
Table 1. Cytotoxicity index -group means and standard deviations
|
MALES |
FEMALES |
||
Group |
Mean |
Standard deviation |
Mean |
Standard deviation |
Negative control 24 h |
0.378 |
0.05 |
0.398 |
0.05 |
Negative control 48 h |
0.380 |
0.05 |
0.375 |
0.05 |
2000 mg/kg 24h |
0.377 |
0.02 |
0.369 |
0.04 |
2000 mg/kg 48h |
0.386 |
0.05 |
0.399 |
0.06 |
Positive control 24h |
0.249* |
0.02 |
0.225* |
0.03 |
Without application |
0.361 |
0.04 |
0.378 |
0.02 |
Table 2. Micronucleated immature erythrocytes - group means and standarddeviations
MALES |
Number of micronucleated IME per animal (per 2000 IME) |
Percentage expression |
||
Group |
Mean |
Standard deviation |
Mean |
Standard deviation |
Negative control 24 h |
2.77 |
0.83 |
0.139 |
0.04 |
Negative control 48 h |
2.58 |
0.54 |
0.129 |
0.03 |
2000 mg/kg 24h |
2.58 |
0.55 |
0.129 |
0.03 |
2000 mg/kg 48h |
2.77 |
0.83 |
0.138 |
0.04 |
Positive control 24 h |
15.73* |
1.60 |
0.786 |
0.08 |
Without application |
2.17 |
0.82 |
0.109 |
0.04 |
Table 3. Micronucleated immature erythrocytes - group means and standard deviations
FEMALES |
Number of micronucleated IME per animal (per 2000 IME) |
Percentage expression |
||
Group |
Mean |
Standard deviation |
Mean |
Standard deviation |
Negative control 24 h |
2.38 |
0.88 |
0.119 |
0.04 |
Negative control 48 h |
2.19 |
0.80 |
0.108 |
0.04 |
2000 mg/kg 24h |
2.16 |
0.80 |
0.108 |
0.04 |
2000 mg/kg 48h |
2.78 |
1.08 |
0.139 |
0.05 |
Positive control 24 h |
18.50* |
2.07 |
0.925 |
0.10 |
Without application |
2.55 |
0.52 |
0.128 |
0.03 |
IME – immature erythrocytes
Applicant's summary and conclusion
- Conclusions:
- Under the experimental conditions described, the test substance induced no cytogenetic damage as assessed in the micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.